Compared with HC, calcium/calmodulin kinase IV (CaMK4), which can target podocytes by restraining nephrin transcription, expresses increasingly in podocytes of LN patients (Maeda et al., 2018). This evidence concerns the gene CAMK4 and lobular neoplasia.